OXYCODONE KAPSLER - AN OVERVIEW

The concomitant use of oxycodone HCl with all cytochrome P450 3A4 inhibitors might result in a rise in oxycodone plasma concentrations, which could maximize or extend adverse reactions and should result in probably fatal respiratory despair. Also, discontinuation of a concomitantly employed cytochrome P450 3A4 inducer might result in a rise in oxyc